GENE ONLINE|News &
Opinion
Blog

Oncology
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
ODAC Votes Against Oncopeptides’ and Spectrum’s New Oncology Drugs
2022-09-26
ESMO 2022: Promising Trials Highlights That Are Worth Following
2022-09-21
MD Anderson and Radiopharm Theranostics Team Up to Develop Oncology Therapies
2022-09-14
Incyte’s Rare Cancer Drug Snags Second FDA Approval
2022-08-29
NIH Provides $23 Million to Fund Telehealth Cancer Care Research
2022-08-22
Genentech Bets $650 Million Biobucks on China’s Jemincare’s Prostate Cancer Prospect
2022-08-19
Sanofi Abandons SERD Candidate After Second Breast Cancer Clinical Trial Blow
2022-08-18
Bristol Myers Squibb Completes Third Largest Acquisition of 2022
2022-08-17
Ipsen Completes $247 Million Oncology Buyout Of Epizyme
2022-08-15
Cancer Research UK and Sosei Heptares Set for First Human Trial of EP4 Antagonist
2022-07-22
Orion Collects $290 Million From Merck in Prostate Cancer Development Collaboration
2022-07-14
ADC Therapeutics and Sobi Sign $435 Million Deal to Expand Blood Cancer Drug’s Market
2022-07-11
MorphoSys Thins Pipeline For Potential $1 Billion Deal While Progressing Oncology Ambitions
2022-06-16
BMS Buys Turning Point Therapeutics For $4.1 Billion, Bringing In Lung Cancer Drug
2022-06-06
1 2 3 4 6
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top